BE Biosol partners Gates Foundation to expand ferric carboxymaltose access globally
The story in brief
BE Biosol and the Gates Foundation have signed an agreement to scale ferric carboxymaltose production for anaemia treatment. The collaboration targets low- and middle-income countries, especially in Africa, where iron deficiency anaemia is widespread. The Gates Foundation will support BE Biosol’s scaling efforts and clinical development of the intravenous iron therapy.